Amedeo Smart

Free Medical Literature Service


 

Amedeo

Obstructive Lung Diseases

  Free Subscription

Articles published in
Allergy
    August 2022
  1. VARRICCHI G, Ferri S, Pepys J, Poto R, et al
    Biologics and Airway Remodeling in Severe Asthma.
    Allergy. 2022 Aug 11. doi: 10.1111/all.15473.
    >> Share

  2. CARUSO C, Colantuono S, Ciasca G, Basile U, et al
    Different aspects of severe asthma in real life: role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity.
    Allergy. 2022 Aug 3. doi: 10.1111/all.15466.
    >> Share

  3. MUMBY S, Kermani NZ, Garnett JP, Pavlidis S, et al
    CEACAM5 is an IL-13-regulated epithelial gene that mediates transcription in type-2 (T2) high severe asthma.
    Allergy. 2022 Aug 2. doi: 10.1111/all.15465.
    >> Share

  4. KARLINA R, Flexeder C, Musiol S, Bhattacharyya M, et al
    Differential effects of lung inflammation on insulin resistance in humans and mice.
    Allergy. 2022;77:2482-2497.
    >> Share

    July 2022
  5. PAPI A, Corren J, Castro M, Domingo C, et al
    Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma.
    Allergy. 2022 Jul 28. doi: 10.1111/all.15456.
    >> Share

  6. JEONG JS, Choi JY, Kim JS, Park SO, et al
    SARS-CoV-2 infection in severe asthma is associated with worsening of COVID-19 through respiratory NLRP3 inflammasome activation.
    Allergy. 2022 Jul 24. doi: 10.1111/all.15452.
    >> Share

  7. HE A, Chen J, Guan J, Huang Y, et al
    Selective eosinophil necroptosis contributes to airway inflammation and remodeling in asthma.
    Allergy. 2022 Jul 20. doi: 10.1111/all.15448.
    >> Share

  8. MAGGI E, Parronchi P, Azzarone BG, Moretta L, et al
    A pathogenic integrated view explaining the different endotypes of asthma and allergic disorders.
    Allergy. 2022 Jul 16. doi: 10.1111/all.15445.
    >> Share

  9. BENAMAR M, Harb H, Chen Q, Wang M, et al
    A Common IL-4 Receptor Variant Promotes Asthma Severity via a Treg Cell GRB2-IL-6-Notch4 Circuit.
    Allergy. 2022 Jul 16. doi: 10.1111/all.15444.
    >> Share

  10. DEVRIES A, McCauley K, Fadrosh D, Fujimura KE, et al
    Maternal Prenatal Immunity, Neonatal Trained Immunity, and Early Airway Microbiota Shape Childhood Asthma Development.
    Allergy. 2022 Jul 16. doi: 10.1111/all.15442.
    >> Share

  11. KIM JG, Zhang A, Rauseo AM, Goss CW, et al
    The nasopharyngeal and salivary microbiomes in COVID-19 patients with and without asthma.
    Allergy. 2022 Jul 15. doi: 10.1111/all.15438.
    >> Share

  12. NAVARATNA S, Burgess J, Waidyatillake N, Peters RL, et al
    Reply to the correspondence: Bacillus Calmette-Guerin vaccination to prevent childhood asthma-A revised analysis.
    Allergy. 2022;77:2264-2265.
    >> Share

  13. PITTET LF, Curtis N
    Bacillus Calmette-Guerin vaccination to prevent childhood asthma: A revised meta-analysis.
    Allergy. 2022;77:2262-2263.
    >> Share

  14. DIVER S, Haldar K, McDowell PJ, Busby J, et al
    Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation.
    Allergy. 2022 Jul 1. doi: 10.1111/all.15425.
    >> Share

  15. LEE SE, Hopkins C, Mullol J, Msihid J, et al
    Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
    Allergy. 2022;77:2211-2221.
    >> Share

    June 2022
  16. RADZIKOWSKA U, Baerenfaller K, Cornejo-Garcia JA, Karaaslan C, et al
    Omics technologies in allergy and asthma research: an EAACI position paper.
    Allergy. 2022 Jun 17. doi: 10.1111/all.15412.
    >> Share

  17. CAIT A, Wedel A, Arntz JL, Duinkerken J, et al
    Prenatal antibiotic exposure, asthma and the atopic march: A systematic review and meta-analysis.
    Allergy. 2022 Jun 11. doi: 10.1111/all.15404.
    >> Share

  18. OWORA AH, Li R, Tepper RS, Ramsey CD, et al
    Impact of time-varying confounders on the association between early-life allergy sensitization and the risk of current asthma: a post-hoc analysis of a birth cohort.
    Allergy. 2022 Jun 10. doi: 10.1111/all.15403.
    >> Share

  19. STARK JM, Liu J, Tibbitt CA, Christian M, et al
    A recombinant multimeric dog allergen prevents airway hyperresponsiveness in a model of asthma marked by vigorous TH 2 and TH 17 cell responses.
    Allergy. 2022 Jun 3. doi: 10.1111/all.15399.
    >> Share

    May 2022
  20. OOKA T, Raita Y, Fujiogi M, Freishtat RJ, et al
    Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma.
    Allergy. 2022 May 27. doi: 10.1111/all.15390.
    >> Share

  21. ANDIAPPAN AK, Puan KJ, Sio YY, Ally F, et al
    Functional CTLA-4 variants associate to both allergic asthma and rhinitis potentially by modulating naive regulatory T cells.
    Allergy. 2022 May 24. doi: 10.1111/all.15386.
    >> Share

  22. CARRARO S, di Palmo E, Licari A, Barni S, et al
    Metabolomics to identify omalizumab responders among children with severe asthma: a prospective study.
    Allergy. 2022 May 23. doi: 10.1111/all.15385.
    >> Share

  23. KALLIERI M, Zervas E, Fouka E, Porpodis K, et al
    RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: evaluating the multiple components of response.
    Allergy. 2022 May 20. doi: 10.1111/all.15382.
    >> Share

  24. LOMMATZSCH M, Suhling H, Korn S, Bergmann KC, et al
    Safety of combining biologics in severe asthma: asthma-related and unrelated combinations.
    Allergy. 2022 May 18. doi: 10.1111/all.15379.
    >> Share

  25. SOZENER ZC, Cevhertas L, Satitsuksanoa P, van de Veen W, et al
    Innate lymphoid cell subsets in obese asthma patients: Difference in activated cells in peripheral blood and their relationship to disease severity.
    Allergy. 2022 May 18. doi: 10.1111/all.15378.
    >> Share

  26. KHALFAOUI L, Symon FA, Couillard S, Hargadon B, et al
    Airway remodelling rather than cellular infiltration characterises both type2 cytokine biomarker-high and -low severe asthma.
    Allergy. 2022 May 17. doi: 10.1111/all.15376.
    >> Share

  27. ACKLAND J, Barber C, Heinson A, Azim A, et al
    NTHi infection of pulmonary macrophages drives neutrophilic inflammation in severe asthma.
    Allergy. 2022 May 16. doi: 10.1111/all.15375.
    >> Share

  28. XING Y, Wang MH, Leung TF, Wong CK, et al
    Poultry exposure and environmental protection against asthma in rural children.
    Allergy. 2022 May 9. doi: 10.1111/all.15365.
    >> Share

  29. SADLIER C, Albrich WC, Neogi U, Lunjani N, et al
    Metabolic rewiring and serotonin depletion in patients with postacute sequelae of COVID-19.
    Allergy. 2022;77:1623-1625.
    >> Share

    April 2022
  30. FARRAIA M, Paciencia I, Mendes FC, Cavaleiro Rufo J, et al
    Cost-effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma.
    Allergy. 2022 Apr 22. doi: 10.1111/all.15321.
    >> Share

  31. VAN DER BURG N, Stenberg H, Bjermer L, Diamant Z, et al
    Cysteinyl-leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics.
    Allergy. 2022 Apr 22. doi: 10.1111/all.15319.
    >> Share

  32. HARB H, Chatila TA
    Recent Patents in Allergy/Immunology: Method for treating asthma or allergic disease via anti-Notch4 mAb.
    Allergy. 2022 Apr 19. doi: 10.1111/all.15317.
    >> Share

  33. RASMUSSEN SM, Halvard Hansen ES, Stensrud T, Radon K, et al
    Asthma endotypes in elite athletes: A cross-sectional study of European athletes participating in the Olympic Games.
    Allergy. 2022 Apr 15. doi: 10.1111/all.15313.
    >> Share

  34. WENG N, Miller M, Pham AK, Komor AC, et al
    Single-base editing of rs12603332 on chromosome 17q21 with a cytosine base editor regulates ORMDL3 and ATF6alpha expression.
    Allergy. 2022;77:1139-1149.
    >> Share

  35. MULLOL J, Laidlaw TM, Bachert C, Mannent LP, et al
    Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
    Allergy. 2022;77:1231-1244.
    >> Share

    March 2022
  36. FARRAIA M, Paciencia I, Castro Mendes F, Cavaleiro Rufo J, et al
    Allergen immunotherapy for asthma prevention: A systematic review and meta-analysis of randomized and non-randomized controlled studies.
    Allergy. 2022 Mar 28. doi: 10.1111/all.15295.
    >> Share

  37. LI Z, Feng Y, Liu H, Yang H, et al
    Single-cell transcriptomics of mouse lung reveal inflammatory memory neutrophils in allergic asthma.
    Allergy. 2022 Mar 21. doi: 10.1111/all.15286.
    >> Share

  38. PAT Y, Ruckert B, Ogulur I, Yazici D, et al
    Differentiation of bronchial epithelial spheroids in the presence of IL-13 recapitulates characteristic features of asthmatic airway epithelia.
    Allergy. 2022 Mar 10. doi: 10.1111/all.15279.
    >> Share

  39. ZUBERBIER T, Abdul Latiff AH, Abuzakouk M, Aquilina S, et al
    The international EAACI/GA(2)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
    Allergy. 2022;77:734-766.
    >> Share

  40. PAVORD ID, Bel EH, Bourdin A, Chan R, et al
    From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.
    Allergy. 2022;77:778-797.
    >> Share

    February 2022
  41. HAAHTELA T, Jantunen J, Saarinen K, Tommila E, et al
    Managing the allergy & asthma epidemic in 2020s - lessons from the Finnish experience.
    Allergy. 2022 Feb 24. doi: 10.1111/all.15266.
    >> Share

  42. SOKOLOWSKA M, Rovati GE, Diamant Z, Untersmayr E, et al
    Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19.
    Allergy. 2022 Feb 16. doi: 10.1111/all.15258.
    >> Share

  43. JUTEL M, Torres MJ, Palomares O, Akdis CA, et al
    COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals - EAACI recommendations.
    Allergy. 2022 Feb 11. doi: 10.1111/all.15252.
    >> Share

  44. SOUSA-PINTO B, Fonseca JA, Gemicioglu B, Regateiro FS, et al
    Patient-reported outcome measures (PROMs) using the MASK-air(R) app in severe asthma.
    Allergy. 2022 Feb 8. doi: 10.1111/all.15248.
    >> Share

  45. CERPS S, Sverrild A, Ramu S, Nieto-Fontarigo JJ, et al
    House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma.
    Allergy. 2022 Feb 3. doi: 10.1111/all.15243.
    >> Share

  46. FIETEN KB, Drijver-Messelink MT, Cogo A, Charpin D, et al
    Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper.
    Allergy. 2022 Feb 3. doi: 10.1111/all.15242.
    >> Share

  47. HAYA LK, Mehri R, Somers-Neal S, Van de Mosselaer S, et al
    Automated dander dispersal in a cat Naturalistic Exposure Chamber (NEC).
    Allergy. 2022;77:685-687.
    >> Share

    January 2022
  48. PARR CL, Nystad W, Karlstad O, Oymar K, et al
    Ten year trends of national healthcare costs of asthma, allergic rhinitis and atopic eczema in 3 million Norwegians.
    Allergy. 2022 Jan 20. doi: 10.1111/all.15225.
    >> Share

  49. THEOFANI E, Semitekolou M, Samitas K, Mais A, et al
    TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma.
    Allergy. 2022 Jan 17. doi: 10.1111/all.15221.
    >> Share

  50. NANISHI M, Fujiogi M, Freishtat RJ, Hoptay CE, et al
    Serum periostin among infants with severe bronchiolitis and risk of developing asthma: A prospective multicenter cohort study.
    Allergy. 2022 Jan 9. doi: 10.1111/all.15216.
    >> Share

  51. HUANG Y, Li X, Zhu L, Huang C, et al
    Thrombin cleaves IL-33 and modulates IL-33-activated allergic lung inflammation.
    Allergy. 2022 Jan 7. doi: 10.1111/all.15210.
    >> Share

  52. AGACHE I, Antolin-Amerigo D, de Blay F, Boccabella C, et al
    EAACI position paper on the clinical use of the bronchial allergen challenge: unmet needs and research priorities.
    Allergy. 2022 Jan 2. doi: 10.1111/all.15203.
    >> Share

    December 2021
  53. SOUSA-PINTO B, Filipe Azevedo L, Jutel M, Agache I, et al
    Development and validation of combined symptom-medication scores for allergic rhinitis.
    Allergy. 2021 Dec 21. doi: 10.1111/all.15199.
    >> Share

  54. CORREN J, Pham TH, Gil EG, Salapa K, et al
    Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.
    Allergy. 2021 Dec 16. doi: 10.1111/all.15197.
    >> Share

  55. JANSEN K, Satitsuksanoa P, Wirz OF, Schneider SR, et al
    T regulatory cells from atopic asthmatic individuals show a Th2-like phenotype.
    Allergy. 2021 Dec 4. doi: 10.1111/all.15193.
    >> Share

    November 2021
  56. DELGADO-DOLSET MI, Obeso D, Rodriguez-Coira J, Tarin C, et al
    Understanding uncontrolled severe allergic asthma by integration of omic and clinical data.
    Allergy. 2021 Nov 28. doi: 10.1111/all.15192.
    >> Share

  57. MISHRA A, Majid D, Kandikattu HK, Yadavalli CS, et al
    Role of IL-18 transformed CD274-expressing eosinophils in promoting airway obstruction in experimental asthma.
    Allergy. 2021 Nov 20. doi: 10.1111/all.15180.
    >> Share

    October 2021
  58. LUNDING LP, Skouras DB, Vock C, Dinarello CA, et al
    The NLRP3 Inflammasome Inhibitor, OLT1177((R)) , Ameliorates Experimental Allergic Asthma in Mice.
    Allergy. 2021 Oct 30. doi: 10.1111/all.15164.
    >> Share

  59. CHANTVEERAWONG T, Sangkangjanavanich S, Chiewchalermsri C, Pradubpongsa P, et al
    Increased circulating CRTH2(+) Tregs are associated with asthma control and exacerbation.
    Allergy. 2021 Oct 22. doi: 10.1111/all.15145.
    >> Share

  60. SOUSA-PINTO B, Anto JM, Sheikh A, de Lusignan S, et al
    Comparison of epidemiologic surveillance and Google Trends data on asthma and allergic rhinitis in England.
    Allergy. 2021 Oct 19. doi: 10.1111/all.15139.
    >> Share

  61. ADJIBADE M, Davisse-Paturet C, Bernard JY, Adel-Patient K, et al
    Enrichment of infant formula with long-chain polyunsaturated fatty acids and risk of infection and allergy in the nationwide ELFE birth cohort.
    Allergy. 2021 Oct 9. doi: 10.1111/all.15137.
    >> Share

  62. PAPI A, Jesenak M, Alfano F, Peroni DG, et al
    The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management.
    Allergy. 2021 Oct 6. doi: 10.1111/all.15131.
    >> Share

  63. GERTH VAN WIJK R, Dahl R
    Pros and cons: Should AIT be considered in all patients with allergic asthma?
    Allergy. 2021 Oct 4. doi: 10.1111/all.15123.
    >> Share

  64. SMITH AM, Ramirez RM, Harper N, Jimenez F, et al
    Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma.
    Allergy. 2021 Oct 4. doi: 10.1111/all.15124.
    >> Share

  65. KIM JM, Im YN, Chung YJ, Youm JH, et al
    Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation.
    Allergy. 2021 Oct 3. doi: 10.1111/all.15121.
    >> Share

    September 2021
  66. KIM YC, Choi S, Sohn KH, Bang JY, et al
    Selenomonas: a marker of asthma severity with the potential therapeutic effect.
    Allergy. 2021 Sep 29. doi: 10.1111/all.15114.
    >> Share

  67. RAIFER H, Schulz AR, Theodorou J, Romero-Olmedo AJ, et al
    Mass cytometry-based identification of a unique T-cell signature in childhood allergic asthma.
    Allergy. 2021 Sep 26. doi: 10.1111/all.15110.
    >> Share

  68. KHALEVA E, Knibb R, DunnGalvin A, Vazquez-Ortiz M, et al
    Perceptions of adolescents and young adults with allergy and/or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey.
    Allergy. 2021 Sep 26. doi: 10.1111/all.15109.
    >> Share

  69. MAURER DJ, Liu C, Xepapadaki P, Stanic B, et al
    Physical activity in asthma control and its immune modulatory effect in asthmatic preschoolers.
    Allergy. 2021 Sep 21. doi: 10.1111/all.15105.
    >> Share

  70. MAJUMDAR S, Bhattacharjee S, Jana T, Saha S, et al
    DAAB-V2: Updated database of allergy and asthma biomarkers.
    Allergy. 2021 Sep 20. doi: 10.1111/all.15100.
    >> Share

  71. NWANAJI-ENWEREM JC, Osborne A, Cardenas A
    Nasal Epigenetic Age and Systemic Steroid Response in Pediatric Emergency Department Asthma Patients.
    Allergy. 2021 Sep 19. doi: 10.1111/all.15102.
    >> Share

  72. LUU QQ, Cao TBT, Shin YS, Yang EM, et al
    Sputum ANA serves as a biomarker for severe asthma.
    Allergy. 2021 Sep 16. doi: 10.1111/all.15086.
    >> Share

  73. FRICKER M, Qin L, Sanchez-Ovando S, Simpson JL, et al
    An altered sputum macrophage transcriptome contributes to the neutrophilic asthma endotype.
    Allergy. 2021 Sep 12. doi: 10.1111/all.15087.
    >> Share

  74. MOLINSKA K, Latek M, Rychlik B, Lach J, et al
    House dust mite sensitization and frequent antibiotic courses may suppress remission of rhinosinusitis and asthma symptoms in young children.
    Allergy. 2021 Sep 12. doi: 10.1111/all.15085.
    >> Share

  75. BLONDAL V, Janson C, Sundbom F, Borres MP, et al
    Asthma in combination with rhinitis and eczema is associated with a higher degree of type-2 inflammation and symptom burden than asthma alone.
    Allergy. 2021 Sep 6. doi: 10.1111/all.15082.
    >> Share

  76. AGUSTI A, Fabbri L, Lahousse L, Singh D, et al
    Single inhaler triple therapy (SITT) in asthma: systematic review and practice implications.
    Allergy. 2021 Sep 3. doi: 10.1111/all.15076.
    >> Share

  77. FORSTER F, Ege MJ, Gerlich J, Weinmann T, et al
    Trajectories of asthma and allergy symptoms from childhood to adulthood.
    Allergy. 2021 Sep 2. doi: 10.1111/all.15075.
    >> Share

    August 2021
  78. JANTUNEN J, Kauppi P, Linna M, Makela M, et al
    Real-world evidence of reduced disability costs during the Finnish Allergy Programme 2008-2018.
    Allergy. 2021 Aug 30. doi: 10.1111/all.15070.
    >> Share

  79. SCHRODER A, Lunding LP, Zissler UM, Vock C, et al
    IL-37 regulates allergic inflammation by counterbalancing pro-inflammatory IL-1 and IL-33.
    Allergy. 2021 Aug 30. doi: 10.1111/all.15072.
    >> Share

  80. ZHAN C, Liu J, Li B, Xu R, et al
    Group 2 Innate Lymphoid Cells in Patients with Non-Asthmatic Eosinophilic Bronchitis.
    Allergy. 2021 Aug 29. doi: 10.1111/all.15068.
    >> Share

  81. SU ZQ, Zhou ZQ, Guan WJ, Fan MY, et al
    Airway remodeling and bronchodilator responses in asthma assessed by endobronchial optical coherence tomography.
    Allergy. 2021 Aug 26. doi: 10.1111/all.15062.
    >> Share

  82. AGACHE I, Eguiluz-Gracia I, Cojanu C, Laculiceanu A, et al
    Advances and highlights in asthma in 2021.
    Allergy. 2021 Aug 14. doi: 10.1111/all.15054.
    >> Share

  83. TRAMPER-STRANDERS G, Ambrozej D, Arcolaci A, Atanaskovic-Markovic M, et al
    Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseases.
    Allergy. 2021 Aug 13. doi: 10.1111/all.15046.
    >> Share

  84. CLOOTS E, Debeuf N, Deswarte K, Fayazpour F, et al
    IRE1beta does not affect mucus secretion during allergic asthma development in a house dust mite murine model.
    Allergy. 2021 Aug 12. doi: 10.1111/all.15045.
    >> Share

  85. WANG YH, Huang SY, Kuo HP, Fan HY, et al
    N-3 Fatty Acid Supplementation in Asthma Management: A Systematic Review and Meta-analysis.
    Allergy. 2021 Aug 11. doi: 10.1111/all.15043.
    >> Share

    July 2021
  86. KLEIN M, Misme-Aucouturier B, Cheminant MA, de Carvalho M, et al
    Engineering a safe monoclonal anti-human IL-2 that is effective in a murine model of food allergy and asthma.
    Allergy. 2021 Jul 29. doi: 10.1111/all.15029.
    >> Share

  87. HOCHGERNER M, Sturm EM, Schnoegl D, Kwapiszewska G, et al
    Low oxygen-levels decrease adaptive immune responses and ameliorate experimental asthma in mice.
    Allergy. 2021 Jul 26. doi: 10.1111/all.15020.
    >> Share

  88. CONDE E, Bruhns P, Serra V, Reber LL, et al
    Recent Patents in Allergy and Immunology: Development and preclinical evaluation of a vaccine targeting IL-4 and IL-13 for the treatment of allergic asthma.
    Allergy. 2021 Jul 5. doi: 10.1111/all.14998.
    >> Share

  89. LOMMATZSCH M, Klein M, Stoll P, Virchow JC, et al
    Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma.
    Allergy. 2021 Jul 3. doi: 10.1111/all.14997.
    >> Share

  90. LOURENCO O, Cardoso A, Monico B, Gama JMR, et al
    beta2-adrenergic agonists and doping: Where do we stand?
    Allergy. 2021;76:2320-2321.
    >> Share

  91. TUBITA V, Callejas-Diaz B, Roca-Ferrer J, Marin C, et al
    Role of microRNAs in inflammatory upper airway diseases.
    Allergy. 2021;76:1967-1980.
    >> Share

    June 2021
  92. GIANG N, Mars M, Moreau M, Mejia JE, et al
    Separation of the CaV 1.2-CaV 1.3 calcium channel duo prevents type-2 allergic airway inflammation.
    Allergy. 2021 Jun 28. doi: 10.1111/all.14993.
    >> Share

  93. URBANO A, Plaza J, Turon S, Pujol A, et al
    Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma.
    Allergy. 2021 Jun 26. doi: 10.1111/all.14988.
    >> Share

  94. WIRZ OF, Jansen K, Satitsuksanoa P, van de Veen W, et al
    Experimental rhinovirus infection induces an antiviral response in circulating B cells which is dysregulated in patients with asthma.
    Allergy. 2021 Jun 25. doi: 10.1111/all.14985.
    >> Share

  95. SIROUX V, Boudier A, Bousquet J, Dumas O, et al
    Trajectories of IgE sensitization to allergen molecules from childhood to adulthood and respiratory health in the EGEA cohort.
    Allergy. 2021 Jun 25. doi: 10.1111/all.14987.
    >> Share

  96. NAIR P, O'Byrne PM
    Medical Algorithms: Approach to Adult Asthma Exacerbations.
    Allergy. 2021 Jun 4. doi: 10.1111/all.14976.
    >> Share

  97. EGGERT LE, He Z, Collins W, Lee AS, et al
    Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19.
    Allergy. 2021 Jun 3. doi: 10.1111/all.14972.
    >> Share

  98. LOSOL P, Kim SH, Ahn S, Lee S, et al
    Genetic variants in the TLR-related pathway and smoking exposure alter the upper airway microbiota in adult asthmatic patients.
    Allergy. 2021 Jun 1. doi: 10.1111/all.14970.
    >> Share

  99. ASAYAMA K, Kobayashi T, D'Alessandro-Gabazza CN, Toda M, et al
    Corrigendum for: "Protein S protects against allergic bronchial asthma by modulating Th1/Th2 balance. Allergy 2020 Sept; 75 (9) 2267-2278".
    Allergy. 2021;76:1946-1947.
    >> Share

  100. HIGHAM A, Beech A, Wolosianka S, Jackson N, et al
    Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease.
    Allergy. 2021;76:1861-1864.
    >> Share

  101. BLAIS CM, Davis BE, Nair P, Cockcroft DW, et al
    Direct and indirect bronchoprovocation tests in dose-response studies of inhaled corticosteroids: Past, present, and future directions.
    Allergy. 2021;76:1679-1692.
    >> Share

    May 2021
  102. MOYA B, Mukherjee M, Nair P
    Notch4, uncovering an immunomodulator in allergic asthma.
    Allergy. 2021 May 29. doi: 10.1111/all.14968.
    >> Share

  103. TULI JF, Ramezanpour M, Cooksley C, Psaltis AJ, et al
    Association between mucosal barrier disruption by Pseudomonas aeruginosa exoproteins and asthma in patients with chronic rhinosinusitis.
    Allergy. 2021 May 25. doi: 10.1111/all.14959.
    >> Share

  104. PFAAR O, Bergmann KC, Bonini S, Compalati E, et al
    Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.
    Allergy. 2021 May 24. doi: 10.1111/all.14957.
    >> Share

  105. KIM KW, Kim DY, Yoon D, Kim KK, et al
    Genome-wide association study identifies TNFSF15associated with childhood asthma.
    Allergy. 2021 May 22. doi: 10.1111/all.14952.
    >> Share

  106. VENTER C, Palumbo MP, Glueck DH, Sauder KA, et al
    The Maternal Diet Index in Pregnancy is associated with offspring allergic diseases: The Healthy Start Study.
    Allergy. 2021 May 21. doi: 10.1111/all.14949.
    >> Share

  107. CANONICA GW, Harrison TW, Chanez P, Menzella F, et al
    Benralizumab Improves Symptoms of Patients with Severe, Eosinophilic Asthma with a Diagnosis of Nasal Polyposis.
    Allergy. 2021 May 12. doi: 10.1111/all.14902.
    >> Share

  108. HAAHTELA T, Alenius H, Lehtimaki J, Sinkkonen A, et al
    Immunological resilience and biodiversity for prevention of allergic diseases and asthma.
    Allergy. 2021 May 6. doi: 10.1111/all.14895.
    >> Share

  109. THURMANN L, Herberth G, Seiwert B, Schlittenbauer L, et al
    Prenatal paraben exposure and atopic dermatitis-related outcomes among children.
    Allergy. 2021 May 2. doi: 10.1111/all.14890.
    >> Share

    April 2021
  110. HEMMER W, Sestak-Greinecker G, Braunsteiner T, Wantke F, et al
    Molecularsensitization patterns in animal allergy: relationship with clinical relevance and pet ownership.
    Allergy. 2021 Apr 29. doi: 10.1111/all.14885.
    >> Share

  111. MASPERO JF, FitzGerald JM, Pavord ID, Rice MS, et al
    Dupilumab efficacy in adolescents with uncontrolled, moderate-to-severe asthma: LIBERTY ASTHMA QUEST.
    Allergy. 2021 Apr 27. doi: 10.1111/all.14872.
    >> Share

  112. MINDAYE ST, Sun C, Esfahani SAZ, Matsui EC, et al
    Diversity and complexity of mouse allergens in urine, house dust, and allergen extracts assessed with an immuno-allergomic approach.
    Allergy. 2021 Apr 17. doi: 10.1111/all.14860.
    >> Share

  113. CHAWES BL, MygindWolsk H, Jakob Carlsson C, Rasmussen MA, et al
    Neonatal Airway Immune Profiles and Asthma and Allergy Endpoints in Childhood.
    Allergy. 2021 Apr 16. doi: 10.1111/all.14862.
    >> Share

  114. ALLAM VSRR, Faiz A, Lam M, Rathnayake SNH, et al
    RAGE and TLR4 differentially regulate airway hyperresponsiveness: Implications for COPD.
    Allergy. 2021;76:1123-1135.
    >> Share

    March 2021
  115. XIE Y, Ju X, Beaudin S, Wiltshire L, et al
    Effect of Intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitics with mild asthma.
    Allergy. 2021 Mar 30. doi: 10.1111/all.14835.
    >> Share

  116. EGUILUZ-GRACIA I, van den Berge M, Boccabella C, Bonini M, et al
    Real-life impact of COVID-19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section.
    Allergy. 2021 Mar 27. doi: 10.1111/all.14831.
    >> Share

  117. COOPER PJ, Chis Ster I, Chico ME, Vaca M, et al
    Impact of early life geohelminths on wheeze, asthma, and atopy in Ecuadorian children at 8 years.
    Allergy. 2021 Mar 20. doi: 10.1111/all.14821.
    >> Share

  118. HIRAI K, Uehara S, Shirai T, Rachi Y, et al
    Benralizumab restores gene and microRNA expression involved in steroid sensitivity in severe asthma.
    Allergy. 2021 Mar 19. doi: 10.1111/all.14819.
    >> Share

  119. HAGEMANN J, Onorato GL, Jutel M, Akdis CA, et al
    Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold- An ARIA-EAACI-GA(2) LENconsensus.
    Allergy. 2021 Mar 17. doi: 10.1111/all.14815.
    >> Share

  120. LAMMERS A, Brinkman P, Te Nijenhuis L, de Vries R, et al
    Increased day-to-day fluctuations in exhaled breath profiles aftera rhinovirus challenge in asthma.
    Allergy. 2021 Mar 11. doi: 10.1111/all.14811.
    >> Share

  121. GAJEWSKI A, Gawrysiak M, Szewczyk R, Gulbas I, et al
    IL-33 augments the effect of rhinovirus HRV16 on inflammatory activity of human lung vascular endothelium - possible implications for rhinoviral asthma exacerbations.
    Allergy. 2021 Mar 8. doi: 10.1111/all.14806.
    >> Share

  122. HEFFLER E, Detoraki A, Contoli M, Papi A, et al
    Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
    Allergy. 2021;76:961-962.
    >> Share

  123. ALBERCA RW, Yendo T, Aoki V, Sato MN, et al
    Asthmatic patients and COVID-19: Different disease course?
    Allergy. 2021;76:963-965.
    >> Share

  124. KLIMEK L, Jutel M, Bousquet J, Agache I, et al
    Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper.
    Allergy. 2021;76:677-688.
    >> Share

    February 2021
  125. HOU A, Silverberg JI
    Increasing rates of influenza vaccination were associated with lower asthma prevalence in United States children.
    Allergy. 2021 Feb 23. doi: 10.1111/all.14790.
    >> Share

  126. PAPADOPOULOS NG, Mathioudakis AG, Custovic A, Deschildre A, et al
    Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort.
    Allergy. 2021 Feb 20. doi: 10.1111/all.14787.
    >> Share

  127. MUKHERJEE M, Agache I
    IL-13 signature in severe adult asthmatics with airway neutrophilia: a new endotype to treat!
    Allergy. 2021 Feb 14. doi: 10.1111/all.14772.
    >> Share

  128. NIESSEN NM, Gibson PG, Baines KJ, Barker D, et al
    Sputum TNF markers are increased in neutrophilic and severe asthma andarereduced by azithromycin treatment.
    Allergy. 2021 Feb 11. doi: 10.1111/all.14768.
    >> Share

  129. NAVARATNA S, Estcourt MJ, Burgess J, Waidyatillake N, et al
    Childhood Vaccination and Allergy: A Systematic Review and Meta-analyses.
    Allergy. 2021 Feb 11. doi: 10.1111/all.14771.
    >> Share

  130. POHLMEIER L, Sonar S, Rodewald HR, Kopf M, et al
    Comparative analysis of the role of mastcells in murine asthma models using Kit-sufficient mast cell-deficient animals.
    Allergy. 2021 Feb 9. doi: 10.1111/all.14765.
    >> Share

  131. CAZZOLA M, Calzetta L, Matera MG
    Long-acting muscarinic antagonists and small airways in asthma: which link?
    Allergy. 2021 Feb 9. doi: 10.1111/all.14766.
    >> Share

  132. ADEL-PATIENT K, Grauso M, Abou-Taam R, Guillon B, et al
    Immune signatures distinguish frequent from non-frequent exacerbators among children with severe asthma.
    Allergy. 2021 Feb 5. doi: 10.1111/all.14759.
    >> Share

    January 2021
  133. MENDEZ-ENRIQUEZ E, Alvarado-Vazquez PA, Abma W, Simonson OE, et al
    Mast cell-derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite-induced experimental asthma.
    Allergy. 2021 Jan 24. doi: 10.1111/all.14748.
    >> Share

  134. MENDEZ-ENRIQUEZ E, Abigail Alvarado-Vazquez P, Abma W, Simonson OE, et al
    Mast cell-derived serotonin enhances methacholine airway hyperresponsiveness in house dust mite-induced experimental asthma.
    Allergy. 2021 Jan 23. doi: 10.1111/all.14749.
    >> Share

  135. JIMENEZ-RODRIGUEZ TW, Berges-Gimeno MP, Barranco R, Bartra J, et al
    Management of hypersensitivity reactions to chemotherapy and biologic agents: A survey of ARADyAL (Asthma, Allergic and Adverse Reactions Network) Spanish Allergy Services.
    Allergy. 2021 Jan 21. doi: 10.1111/all.14743.
    >> Share

  136. FRICKER M, McDonald VM, Winter NA, Baines KJ, et al
    Molecular markers of type 2 airway inflammation are similarbetween eosinophilic severe asthma and eosinophilic COPD.
    Allergy. 2021 Jan 20. doi: 10.1111/all.14741.
    >> Share

  137. BOUTE M, Ait Yahia S, Nanou J, Alvarez-Simon D, et al
    Direct activation of the aryl hydrocarbon receptor by dog allergen participates in airway neutrophilic inflammation.
    Allergy. 2021 Jan 19. doi: 10.1111/all.14740.
    >> Share

  138. D'ANCONA G, Kavanagh JE, Dhariwal J, Hearn AP, et al
    Adherence to Inhaled Corticosteroids and Clinical Outcomes Following a Year of Benralizumab Therapy for Severe Eosinophilic Asthma.
    Allergy. 2021 Jan 12. doi: 10.1111/all.14737.
    >> Share

  139. ABDEL-AZIZ MI, Zounemat Kermani N, Neerincx AH, Vijverberg SJH, et al
    Association of endopeptidases, involved in SARS-CoV-2 infection, with microbial aggravation in sputum of severe asthma.
    Allergy. 2021 Jan 7. doi: 10.1111/all.14731.
    >> Share

  140. AZIM A, Green B, Lau L, Rupani H, et al
    Peripheral airways type 2 inflammation, neutrophilia and microbial dysbiosis in severe asthma.
    Allergy. 2021 Jan 7. doi: 10.1111/all.14732.
    >> Share

  141. WAERN I, Taha S, Lorenzo J, Montpeyo D, et al
    Carboxypeptidase inhibition by NvCI suppresses airway hyperreactivity in a mouse asthma model.
    Allergy. 2021 Jan 2. doi: 10.1111/all.14730.
    >> Share

  142. LEE H, Kim SH, Kim BK, Lee Y, et al
    Characteristics of Specialist-Diagnosed Asthma-COPD Overlap in Severe Asthma: Observations from the Korean Severe Asthma Registry (KoSAR).
    Allergy. 2021;76:223-232.
    >> Share

  143. BOUSQUET J, Anto JM, Bachert C, Haahtela T, et al
    ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.
    Allergy. 2021;76:168-190.
    >> Share

  144. PFALLER B, Jose Yepes-Nunez J, Agache I, Akdis CA, et al
    Biologicals in atopic disease in pregnancy: An EAACI position paper.
    Allergy. 2021;76:71-89.
    >> Share

    December 2020
  145. LARSSON SC, Gill D
    Genetic predisposition to allergic diseases is inversely associated with risk of COVID-19.
    Allergy. 2020 Dec 31. doi: 10.1111/all.14728.
    >> Share

  146. XU J, Meng Y, Jia M, Jiang J, et al
    Epithelial expression and role of secreted STC1 on asthma airway hyperresponsiveness through calcium channel modulation.
    Allergy. 2020 Dec 30. doi: 10.1111/all.14727.
    >> Share

  147. PARRA D, Zakzuk J, Carrasquilla M, Alvis Guzman N, et al
    Cost-effectiveness of the subcutaneous house dust mite allergen immunotherapy plus pharmacotherapy for allergic asthma a mathematical model.
    Allergy. 2020 Dec 29. doi: 10.1111/all.14723.
    >> Share

  148. YANG J, Scicluna BP, van Engelen TSR, Bonta PI, et al
    Transcriptional changes in alveolar macrophages from adults with asthma after allergen challenge.
    Allergy. 2020 Dec 23. doi: 10.1111/all.14719.
    >> Share

  149. LEE H, Choi H, Nam H, Yang B, et al
    Body Mass Index Change and Incident Asthma in Adults: A Nationwide Cohort Study.
    Allergy. 2020 Dec 15. doi: 10.1111/all.14703.
    >> Share

  150. KOENDERMAN L, Hassani M, Mukherjee M, Nair P, et al
    Monitoring eosinophils to guide therapy with Biologics in Asthma: does the compartment matter?
    Allergy. 2020 Dec 10. doi: 10.1111/all.14700.
    >> Share

  151. KAVANAGH J, Hearn A, d'Ancona G, Dhariwal J, et al
    Benralizumab After Sub-optimal Response to Mepolizumab in Severe Eosinophilic Asthma.
    Allergy. 2020 Dec 9. doi: 10.1111/all.14693.
    >> Share

  152. BERTOLINI F, Carriero V, Bullone M, Sprio AE, et al
    Correlation of matrix-related airway remodeling and bradykinin B1 receptor expression with fixed airflow obstruction in severe asthma.
    Allergy. 2020 Dec 7. doi: 10.1111/all.14691.
    >> Share

  153. BOURDIN A, Charriot J, Boissin C, Ahmed E, et al
    Will the asthma revolution fostered by biologics also benefit adult ICU patients?
    Allergy. 2020 Dec 7. doi: 10.1111/all.14688.
    >> Share

  154. ALVARADO-VAZQUEZ PA, Mendez-Enriquez E, Hallgren J
    Use of spirometry-like measurements to monitor house dust mite-induced experimental asthma in mice.
    Allergy. 2020 Dec 2. doi: 10.1111/all.14681.
    >> Share

    November 2020
  155. ZHANG S, He Y, Liang H, Gao J, et al
    Higher environmental composite quality index score and risk of asthma and allergy in Northeast China.
    Allergy. 2020 Nov 28. doi: 10.1111/all.14672.
    >> Share

  156. CHOI HG, Wee JH, Kim SY, Kim JH, et al
    Association between asthma and clinical mortality/morbidity in COVID-19 patients using clinical epidemiologic data from Korean Disease Control & Prevention.
    Allergy. 2020 Nov 28. doi: 10.1111/all.14675.
    >> Share

  157. CAMPO P, Soto Campos G, Moreira A, Quirce S, et al
    Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment.
    Allergy. 2020 Nov 21. doi: 10.1111/all.14668.
    >> Share

  158. WAWRZYNIAK P, Krawczyk K, Acharya S, Tan G, et al
    Inhibition of CpG methylation improves the barrier integrity of bronchial epithelial cells in asthma.
    Allergy. 2020 Nov 19. doi: 10.1111/all.14667.
    >> Share

  159. ZHU T, Zhang X, Chen X, Anthony BP, et al
    Nasal DNA methylation differentiates severe from non-severe asthma in African-American children.
    Allergy. 2020 Nov 11. doi: 10.1111/all.14655.
    >> Share

  160. CARLSSON CJ, Rasmussen MA, Pedersen SB, Wang N, et al
    Airway immune mediator levels during asthma-like symptoms in young children and their possible role in response to azithromycin.
    Allergy. 2020 Nov 4. doi: 10.1111/all.14651.
    >> Share

  161. PFAAR O, van Wijk RG
    Legends of allergy and clinical immunology: Anthony J. Frew - a true European advocate of allergology and clinical immunology.
    Allergy. 2020 Nov 3. doi: 10.1111/all.14648.
    >> Share

    October 2020
  162. WEIDNER J, Bartel S, Kilic A, Zissler UM, et al
    Spotlight on microRNAs in allergy and asthma.
    Allergy. 2020 Oct 31. doi: 10.1111/all.14646.
    >> Share

  163. CARUSO C, Colantuono S, Tolusso B, Di Mario C, et al
    Basophil activation and serum IL-5 levels as possible monitor biomarkers in severe eosinophilic asthma patients treated with anti-IL-5 drugs.
    Allergy. 2020 Oct 25. doi: 10.1111/all.14643.
    >> Share

  164. HAN X, Krempski JW, Nadeau K
    Advances and novel developments in mechanisms of allergic inflammation.
    Allergy. 2020 Oct 17. doi: 10.1111/all.14632.
    >> Share

  165. CARRARD J, Marquillies P, Pichavant M, Visez N, et al
    Chronic exposure to benzo(a)pyrene-coupled nanoparticles worsens inflammation in a mite-induced asthma mouse model.
    Allergy. 2020 Oct 9. doi: 10.1111/all.14619.
    >> Share

  166. KIM S, Jung CG, Lee JY, Kim G, et al
    Characterization of asthma and risk factors for delayed SARS-CoV-2 clearance in adult COVID-19 inpatients in Daegu.
    Allergy. 2020 Oct 4. doi: 10.1111/all.14609.
    >> Share

  167. BOURDIN A, Papi AA, Corren J, Virchow JC, et al
    Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baseline.
    Allergy. 2020 Oct 3. doi: 10.1111/all.14611.
    >> Share

  168. KOW CS, Capstick T, Hasan SS
    Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?
    Allergy. 2020 Oct 2. doi: 10.1111/all.14589.
    >> Share

  169. BUSH A, Saglani S
    Preschool wheeze: Challenges and research prospects reply to: Dr Jartti and Colleagues; in response to our manuscript entitled: Medical algorithm: Diagnosis and treatment of preschool asthma.
    Allergy. 2020;75:2718.
    >> Share

  170. JARTTI T, Papadopoulos NG, Feleszko W
    Reply to: Medical algorithm: Diagnosis and treatment of preschool asthma.
    Allergy. 2020;75:2716-2717.
    >> Share

    September 2020
  171. CEVHERTAS L, Ogulur I, Maurer DJ, Burla D, et al
    Advances and Recent Developments in Asthma in 2020.
    Allergy. 2020 Sep 30. doi: 10.1111/all.14607.
    >> Share

  172. PERKINS TN, Donnell ML, Oury TD
    The Axis of the Receptor for Advanced Glycation Endproducts in Asthma and Allergic Airway Disease.
    Allergy. 2020 Sep 25. doi: 10.1111/all.14600.
    >> Share

  173. CHANG C, Zhang L, Dong F, Liang Y, et al
    Asthma control, self-management and healthcare access during the COVID-19 epidemic in Beijing.
    Allergy. 2020 Sep 18. doi: 10.1111/all.14591.
    >> Share

  174. LYONS SA, Knulst AC, Burney PGJ, Fernandez-Rivas M, et al
    Predicting food allergy: the value of patient history reinforced.
    Allergy. 2020 Sep 7. doi: 10.1111/all.14583.
    >> Share

    August 2020
  175. AMAZOUZ H, de Lauzon-Guillain B, Bourgoin-Heck M, Just J, et al
    Infant feeding clusters are associated with respiratory health and allergy at school age in the PARIS birth cohort.
    Allergy. 2020 Aug 20. doi: 10.1111/all.14568.
    >> Share

    July 2020
  176. AZZANO P, Dufresne E, Poder T, Begin P, et al
    Economic considerations on the usage of biologics in the allergy clinic.
    Allergy. 2020 Jul 13. doi: 10.1111/all.14494.
    >> Share

    June 2020
  177. ROTH-WALTER F, Adcock IM, Benito-Villalvilla C, Bianchini R, et al
    Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO).
    Allergy. 2020 Jun 27. doi: 10.1111/all.14478.
    >> Share

  178. SHI W, Gao Z, Ding Y, Zhu T, et al
    Clinical characteristics of COVID-19 patients combined with allergy.
    Allergy. 2020 Jun 7. doi: 10.1111/all.14434.
    >> Share

    May 2020
  179. SASTRE J, Del Cuvillo A, Colas C, Navarro AM, et al
    Validation of the MASK-air App for assessment of allergic rhinitis.
    Allergy. 2020 May 25. doi: 10.1111/all.14415.
    >> Share

    March 2020
  180. KNIBB RC, Alviani C, Garriga-Baraut T, Mortz CG, et al
    The effectiveness of interventions to improve self-management for adolescents and young adults with allergic conditions: a systematic review.
    Allergy. 2020 Mar 11. doi: 10.1111/all.14269.
    >> Share

  181. VAZQUEZ-ORTIZ M, Angier E, Blumchen K, Comberiati P, et al
    Understanding the challenges faced by adolescents and young adults with allergic conditions: a systematic review.
    Allergy. 2020 Mar 6. doi: 10.1111/all.14258.
    >> Share

  182. LAN F, Zhang N, Bachert C, Zhang L, et al
    Stability of regulatory T cells in T helper 2-biased allergic airway diseases.
    Allergy. 2020 Mar 3. doi: 10.1111/all.14257.
    >> Share

    December 2019
  183. ZHANG HP, Sun YX, Lin Z, Yang G, et al
    CARsomes inhibit airway allergic inflammation in mice by inducing antigen specific Th2 cell apoptosis.
    Allergy. 2019 Dec 17. doi: 10.1111/all.14157.
    >> Share

    September 2019
  184. CAMINATI M, Antolin-Amerigo D, Bonini M, Buelow B, et al
    The EAACI-AAAAI-WAO Junior Members joint survey: a worldwide snapshot of Allergy and Clinical Immunology Specialty.
    Allergy. 2019 Sep 16. doi: 10.1111/all.14052.
    >> Share

    August 2019
  185. ROULA D, Theiler A, Luschnig P, Sturm GJ, et al
    Apolipoprotein A-IV acts as an endogenous anti-inflammatory protein and is reduced in treatment-naive allergic patients and allergen-challenged mice.
    Allergy. 2019 Aug 13. doi: 10.1111/all.14022.
    >> Share

  186. CAO K, Wu J, Li X, Xie H, et al
    T cell receptor repertoire data provides new evidence for hygiene hypothesis of allergic diseases.
    Allergy. 2019 Aug 8. doi: 10.1111/all.14014.
    >> Share

    July 2019
  187. ULLAH MA, Vicente CT, Collinson N, Curren B, et al
    PAG1 limits allergen-induced type 2 inflammation in the murine lung.
    Allergy. 2019 Jul 18. doi: 10.1111/all.13991.
    >> Share

    June 2019
  188. MATRICARDI PM, Dramburg S, Alvarez-Perea A, Antolin-Amerigo D, et al
    The Role of Mobile Health Technologies in Allergy Care: an EAACI Position Paper.
    Allergy. 2019 Jun 22. doi: 10.1111/all.13953.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016